Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (291-300 of 303) with videos related to

Pageof 31
Sort By:
Plos Pathogens|May 17, 2014
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortalitySergio Serrano-Villar, Talia Sainz, Sulggi A Lee, et al.
Plos Pathogens|September 25, 2020
CX3CL1 and IL-15 Promote CD8 T cell chemoattraction in HIV and in atherosclerosisSoumya Panigrahi, Bonnie Chen, Mike Fang, et al.
The Journal of Clinical Investigation|July 20, 2018
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollersRadwa Sharaf, Guinevere Q Lee, Xiaoming Sun, et al.
The Journal of Clinical Investigation|June 21, 2016
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infectionSouheil-Antoine Younes, Michael L Freeman, Joseph C Mudd, et al.
Cell Host & Microbe|January 3, 2023
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapyXiaodong Lian, Kyra W Seiger, Elizabeth M Parsons, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2023
HIV post-treatment controllers have distinct immunological and virological featuresBehzad Etemad, Xiaoming Sun, Yijia Li, et al.
The Journal of Clinical Investigation|May 22, 2018
Lymphoid tissue fibrosis is associated with impaired vaccine responsesCissy Kityo, Krystelle Nganou Makamdop, Meghan Rothenberger, et al.
Plos One|March 8, 2014
Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapyJonathan Z Li, Brad Chapman, Patrick Charlebois, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Viral and Host Mediators of Non-Suppressible HIV-1 ViremiaAbbas Mohammadi, Behzad Etemad, Xin Zhang, et al.
Cell|July 8, 2021
Translocated microbiome composition determines immunological outcome in treated HIV infectionKrystelle Nganou-Makamdop, Aarthi Talla, Ashish Arunkumar Sharma, et al.
Pageof 31

Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
Plos Pathogens|May 17, 2014
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortalitySergio Serrano-Villar, Talia Sainz, Sulggi A Lee, et al.
Plos Pathogens|September 25, 2020
CX3CL1 and IL-15 Promote CD8 T cell chemoattraction in HIV and in atherosclerosisSoumya Panigrahi, Bonnie Chen, Mike Fang, et al.
The Journal of Clinical Investigation|July 20, 2018
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollersRadwa Sharaf, Guinevere Q Lee, Xiaoming Sun, et al.
The Journal of Clinical Investigation|June 21, 2016
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infectionSouheil-Antoine Younes, Michael L Freeman, Joseph C Mudd, et al.
Cell Host & Microbe|January 3, 2023
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapyXiaodong Lian, Kyra W Seiger, Elizabeth M Parsons, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2023
HIV post-treatment controllers have distinct immunological and virological featuresBehzad Etemad, Xiaoming Sun, Yijia Li, et al.
The Journal of Clinical Investigation|May 22, 2018
Lymphoid tissue fibrosis is associated with impaired vaccine responsesCissy Kityo, Krystelle Nganou Makamdop, Meghan Rothenberger, et al.
Plos One|March 8, 2014
Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapyJonathan Z Li, Brad Chapman, Patrick Charlebois, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Viral and Host Mediators of Non-Suppressible HIV-1 ViremiaAbbas Mohammadi, Behzad Etemad, Xin Zhang, et al.
Cell|July 8, 2021
Translocated microbiome composition determines immunological outcome in treated HIV infectionKrystelle Nganou-Makamdop, Aarthi Talla, Ashish Arunkumar Sharma, et al.
Pageof 31